Skip to content

Study · Not a test of the peptide alone · 1992

3 results

[The effect of thymalin on lipid metabolism and the clinical course of ischemic heart disease].

Shustval' NF

Likars'ka sprava1 Sept 1992

PMID1481512 (opens in a new tab)PepBankPUB-01481512
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with exertion stenocardia, complex treatment including thymalin increased thymic factor levels.

    In plain wordsIn patients with exertion stenocardia, complex treatment including thymalin increased thymic factor levels.

    Peptide
    Thymalin
    Outcome
    IncreaseBlood thymic factor
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Complex treatment with inclusion of thymalin resulted in an increase of the thymic factor, normalization of the lipid metabolism increase of the contractile function of the myocardium and, thus, increases the treatment efficacy.
    1 context sentence
    Summary · context
    The effect of the thymus polypeptide factor-thymidin on the lipid spectrum of the blood, thymic factor content in the blood and clinical course of the disease were studied in 156 patients with exertion stenocardia (II-IV functional class).

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with exertion stenocardia, complex treatment including thymalin normalized lipid metabolism.

    In plain wordsIn patients with exertion stenocardia, complex treatment including thymalin normalized lipid metabolism.

    Peptide
    Thymalin
    Outcome
    Direction not reportedLipid metabolism
    Study

    n: not reported in source

    Outcome group
    Lipids · Metabolic and weight

    Source sentences

    Summary
    Complex treatment with inclusion of thymalin resulted in an increase of the thymic factor, normalization of the lipid metabolism increase of the contractile function of the myocardium and, thus, increases the treatment efficacy.
    1 context sentence
    Summary · context
    The effect of the thymus polypeptide factor-thymidin on the lipid spectrum of the blood, thymic factor content in the blood and clinical course of the disease were studied in 156 patients with exertion stenocardia (II-IV functional class).

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with exertion stenocardia, complex treatment including thymalin increased myocardial contractile function.

    In plain wordsIn patients with exertion stenocardia, complex treatment including thymalin increased heart muscle contraction function.

    Peptide
    Thymalin
    Outcome
    IncreaseMyocardial contractile function
    Study

    n: not reported in source

    Outcome group
    Heart function · Cardiovascular

    Source sentences

    Summary
    Complex treatment with inclusion of thymalin resulted in an increase of the thymic factor, normalization of the lipid metabolism increase of the contractile function of the myocardium and, thus, increases the treatment efficacy.
    1 context sentence
    Summary · context
    The effect of the thymus polypeptide factor-thymidin on the lipid spectrum of the blood, thymic factor content in the blood and clinical course of the disease were studied in 156 patients with exertion stenocardia (II-IV functional class).

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.